Friday, September 23rd, 2016

The report provides comprehensive information on the therapeutics under development by Actinium Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

 

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

Complete Report @ https://www.wiseguyreports.com/reports/649760-actinium-pharmaceuticals-inc-product-pipeline-review-2016

 

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

 

Scope

 

- The report provides a snapshot of the pipeline therapeutic landscape of Actinium Pharmaceuticals, Inc.

- The report provides overview of Actinium Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Actinium Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Actinium Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

 

Get Sample Report @ https://www.wiseguyreports.com/sample-request/649760-actinium-pharmaceuticals-inc-product-pipeline-review-2016

 

Reasons to buy

 

- Evaluate Actinium Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Actinium Pharmaceuticals, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Actinium Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 

Have any query @ https://www.wiseguyreports.com/enquiry/649760-actinium-pharmaceuticals-inc-product-pipeline-review-2016

 

Table of Content

 

Key Facts 5

Actinium Pharmaceuticals, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Actinium Pharmaceuticals, Inc. - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Actinium Pharmaceuticals, Inc. - Pipeline Products Glance 12

Actinium Pharmaceuticals, Inc. - Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Actinium Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Actinium Pharmaceuticals, Inc. - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Actinium Pharmaceuticals, Inc. - Drug Profiles 16

Iomab-B 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Actimab-A 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

BC-8Y90 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

BC-8SA 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Actimab-B 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Actimab-Br 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Actimab-C 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Actimab-P 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Monoclonal Antibody Conjugate for Hematological Tumor and Oncology 26

Product Description 26

 

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=649760               

Continued

 

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Actinium Pharmaceuticals market trend, Actinium Pharmaceuticals market segmentation, Actinium Pharmaceuticals market analysis, Actinium Pharmaceuticals market parameters, Actinium Pharmaceuticals industry forecast, Actinium Pharmaceuticals market size, A

Categories

Newsrooms

Sharing

More Formats

View QR Code